AngioDynamics, Inc.ANGONASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank60
3Y CAGR-2.5%
5Y CAGR-5.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-2.5%/yr
vs +0.4%/yr prior
5Y CAGR
-5.3%/yr
Consistent
Acceleration
-2.9pp
Decelerating
Percentile
P60
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$27.69M+5.6%
2025$26.22M-16.8%
2024$31.51M+5.5%
2023$29.88M-2.8%
2022$30.74M-15.5%
2021$36.39M+22.6%
2020$29.68M+0.8%
2019$29.43M+15.6%
2018$25.46M+0.8%
2017$25.27M-